Personal information

Activities

Collapse all

Funding (7)

Establishing a platform to exploit CRISPR/Cas9 for optimal cytotoxic immune responses against tumors

2019-11 to 2020-10 | Grant
University of Fribourg (Fribourg, CH)
Source: Self-asserted source
Jun Abe

Mechanismen der organ-spezifischen Wanderung von CD8+ T Zellen für optimale anti-mikrobielle und anti-tumorale Wirkung

2019-07 to 2020-06 | Grant
Jubiläumsstiftung von Swiss Life (Zurich, CH)
Source: Self-asserted source
Jun Abe

Establishing a platform to exploit CRISPR/Cas9 for optimal cytotoxic immune responses against tumors

2019-01 to 2019-12 | Grant
Werner and Hedy Berger-Janser Foundation for Cancer Research (Bern, CH)
Source: Self-asserted source
Jun Abe

Exploiting CRISPR/Cas9 for optimal cytotoxic immune responses against tumors

2018-10 to 2021-09 | Grant
Vontobel-Stiftung (Zurich, CH)
Source: Self-asserted source
Jun Abe

Reverse Translational Research for Understanding immune response in the Tumor and Identification of Biomarkers

Source: Self-asserted source
Jun Abe via DimensionsWizard

Analysis of the mechanism for the regulation of antibody responses by inflammation-associated remodeling of lymph nodes

Source: Self-asserted source
Jun Abe via DimensionsWizard

Elucidation of the molecular bases of the generation and maintenance of CTL memory by next generation DNA sequencer

Source: Self-asserted source
Jun Abe via DimensionsWizard
How many people are using ORCID?